Sep 13, 2017· Comment submitted by Uni Blake, Scientific Advisor, American Petroleum Institute (API)· EPA-HQ-OPP-2017-0214-0009
Filed on regulations.gov — full text not in the inline record.
EPANonrulemakingEPA-HQ-OPP-2017-0214
FIFRA Scientific Advisory Panel; Notice of Public Meeting: Continuing Development of Alternative High-Throughput Screens to Determine Endocrine Disruption, Focusing on Androgen Receptor, Steroidogenesis, and Thyroid Pathways
RIN
—
Last modified
Jun 13, 2024
Comment window
closed 3191d ago
American Petroleum Institute filings
1
Activity
American Petroleum Institute filed 1 comment on this docket between Sep 13, 2017 and Sep 13, 2017. 3 other organizations filed here. The comment window closed 3191d ago.
What American Petroleum Institute filed (1)
Abstract
The SAP will review and comment on the EPA Endocrine Disruptor Screening Program’s: (1) proposed high-throughput computational model of androgen receptor binding as an alternative to the current Tier 1 androgen receptor assay; (2) development of high-throughput computational model of steroidogenesis; and (3) proposed adverse outcome pathway-based framework for thyroid screening. Non-Rulemaking
View on regulations.gov →Co-filers (3)
See everyone who commented →- American Petroleum InstituteTHIS ORG1 filing · confidence 97%
- Natural Resources Defense Council (NRDC)trade assoc.1 filing · confidence 97%
- The Dow Chemical Companyunverified attribution1 filing · confidence 70%
- The Endocrine Societytrade assoc.1 filing · confidence 85%